Vertex Pharmaceuticals Inc. (VRTX)

Index: Nasdaq 100
-1.18%
-$1.14
$95.80
21:45 30/08/16
$95.80
21:45 30/08/16
DAILY VARIATION
-1.18%
-$1.14
VOLUME
672,575
DATA
52 Week High
$135.45
52 Week Low
$78.40
Shares Issued
247.78m
Market Cap
$23,737.20m
RiskGrade
162
Beta
1.56
MENU

Vertex Pharmaceuticals Inc. Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -45.2% -0.8%
ROCE 0.0%
Latest F'cast
P/E 42.0 9,565.5
PEG -1.6 -1.7
Pr/Revenue 23.3 13.6
Pr/Book 22.0
Latest F'cast
Revenue 77.9% -30.7%
PBT 0.0% n/a
EPS -26.4% -68.9%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2011-12-31 1,410.63 60.44 14.00¢ 237.2 0.0 n/a n/a 0.0%
2012-12-31 1,527.04 -12.38 -50.00¢ -83.8 0.0 n/a n/a 0.0%
2013-12-31 1,211.97 -626.04 -198.00¢ -37.5 0.0 n/a n/a 0.0%
2014-12-31 580.41 -734.88 314.00¢ 37.8 0.0 n/a n/a 0.0%
2015-12-31 1,032.34 -557.80 231.00¢ 54.5 -2.1 -26% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2016-12-31 1,764.59 -14.29 100.85c 9,565.5 -169.8 -56% 0.00c 0.0%
2017-12-31 2,457.76 632.59 312.47c 3,072.5 14.6 210% 0.00c 0.0%

Regulatory News

No results found

Newspaper Links

No results found
No results found